HUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% – Time to Sell?

Shares of HUTCHMED (China) Limited (NASDAQ:HCM) dropped 5.7% during mid-day trading on Friday . The stock traded as low as $15.06 and last traded at $15.22. Approximately 21,656 shares changed hands during trading, a decline of 80% from the average daily volume of 108,708 shares. The stock had previously closed at $16.13.

HUTCHMED Stock Down 7.9 %

The firm’s fifty day moving average is $14.69 and its 200-day moving average is $16.52. The company has a current ratio of 2.81, a quick ratio of 2.68 and a debt-to-equity ratio of 0.07.

Hedge Funds Weigh In On HUTCHMED

A number of institutional investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio raised its stake in shares of HUTCHMED by 49.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,710 shares of the company’s stock worth $39,000 after acquiring an additional 899 shares during the last quarter. Summit Trail Advisors LLC raised its stake in shares of HUTCHMED by 14.4% in the fourth quarter. Summit Trail Advisors LLC now owns 13,090 shares of the company’s stock worth $189,000 after acquiring an additional 1,647 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of HUTCHMED by 10.7% during the fourth quarter. Crossmark Global Holdings Inc. now owns 18,591 shares of the company’s stock worth $268,000 after buying an additional 1,799 shares during the last quarter. Barclays PLC raised its stake in shares of HUTCHMED by 1,483.6% during the fourth quarter. Barclays PLC now owns 2,407 shares of the company’s stock worth $35,000 after buying an additional 2,255 shares during the last quarter. Finally, State Street Corp raised its stake in shares of HUTCHMED by 0.9% during the third quarter. State Street Corp now owns 349,524 shares of the company’s stock worth $6,826,000 after buying an additional 3,078 shares during the last quarter. 8.82% of the stock is owned by institutional investors.

HUTCHMED Company Profile

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.